Abstract
In the beginning of the nineties the National Cancer Institute Surveillance, Epidemiology, and End Results Program calculated the incidence of primary central nervous system non-Hodgkin's lymphoma (PCNSL) as 1:100 000. The incidence of PCNSL has been increasing since the seventies in immunocompetent patients. The main increase, however, is taking place since the mid-eighties and is due to the increase of immunodeficieny and immunosuppression. The risk is 2–6% in AIDS patients according to clinical data and will probably further increase with the length of survival in these patients. Transplant patients carry a risk of 1–5% to develop a PCNSL. The risk is 1–2% for renal, and 2–7% for cardiac, lung or liver transplant recipients. Patients with congenital immune deficiency have a risk of 4%. PCNSL may also present as a secondary malignancy.
Similar content being viewed by others
References
Jellinger KA, Paulus W: Primary central nervous system lymphomas-new pathological developments. J Neuro-Oncol 24: 33–36, 1995
Eby NL, Gruffermann S, Flannelly CM, Schold SC, Vogel FS, Burger PC: Increasing incidence of primary brain lymphoma in the US. Cancer 62: 2461–2465, 1988
Ahsan H, Neugut AI, Bruce JN: Trends in the incidence of primary malignant brain tumors in USA, 1981–1990. Int J Epidemiol 24: 1078–1085, 1995
Ferracini R, Pileri S, Bergmann M, Sabattini E, Rigobello L, Gambacorta M, Galli C, Manetto V, Frank G, Godano U, Spagnolli F, Casadei G, Azzolini U, Falini B, Gullotta F: Non-Hodgkin's lymphomas of the central nervous system. Pathol Res Pract 189: 249–260, 1993
Hochberg FH, Miller DC: Primary central nervous system lymphoma. J Neurosurg 68: 835–853, 1988
O'Neill BP, Tomlinson FH, O'Falloon, Scheithauer BW, Kurtin PJ, O'Neill DB: The continuing increase of primary central nervous system non-Hodgkin's lymphoma (abstract). Ann Neurol 34: 313, 1993
O'Sullivan MG, Whittle IR, Gregor A, IronsideJW: Increasing incidence of CNS primary lymphoma in south-east Scotland (letter). Lancet 338: 895–896, 1991
Baumgartner JE, Rachlin JR, Beckstead JH, Meeker TC, Levy RM, Wara WM, Rosenblum ML: Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodefi-ciency syndrome. J Neurosurg 73: 206–211, 1990
Ling SM, Roach M, Larson DA, Wara WM: Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Ten years of treatment experience at the University of California San Francisco. Cancer 73: 2570–2582, 1994
Penn I, Porat G: Central nervous system lymphomas in organ allograft recipients. Transplantation 59: 240–244, 1995
Fine H, Mayer R: Primary central nervous system lymphomas. Ann Intern Med 119: 1093–1104, 1993
Reni M, Ferreri AJM, Garancini MP, Villa E: Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. Ann Oncol 8: 227–234, 1997
Formenti SC, Gill PS, Lean E, Rarick M, Meyer PR, BoswellW, Petrovich Z, Chak L, Levine AM: Primary central nervous system lymphoma in AIDS. Cancer 63: 1101–1107, 1989
Levy RM, Janssen RS, Bush TJ, Rosenblum ML: Neuroepidemiology of acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 1: 31–40, 1988
Rosenblum ML, Levy RM, Bredesen DE, So YT, Wara W, Ziegler JL: Primary central nervous system lymphomas in patients with AIDS. Ann Neurol 23: S13–S16, 1988
MacMahon EM, Glass JD, Hayward SD, Mann RB, Becker PS, Charache P, McArthur JC, Ambinder RF: Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 338: 969–973, 1991
Goplen AK, Dunlop O, Liestol K, Lingjaerde OC, Bruun JN, Maehlen J: The impact of primary central nervous system lymphoma in AIDS patients: a population-based autopsy study from Oslo. J Acquir Immune Defic Syndr Hum Retrovirol 14: 351–354, 1997
Patchell RA: Primary central nervous system lymphoma in the transplant patient. Neurol Clin 6: 297–303, 1988
Boubenider S, Hiesse C, Goupy C, Kriaa F, Marchand S, Charpentier B: Incidence and consequences of posttransplantation lymphoproliferative disorders. J Nephrol 10: 136–145, 1997
Penn I: Incidence and treatment of neoplasia after transplantation. J Heart Lung Transplant 12: S328–S336, 1993
Penn I: Posttransplantation de novo tumors in liver allograft recipients. Liver Transpl Surg 2: 52–59, 1996
Filipovich AH, Heinitz KJ, Robison LL, Frizzera G: The Immunodeficiency Cancer Registry. A research resource. Am J Pediatr Hematol Oncol 9: 183–184, 1987
Perry GS 3rd, Spector BD, Schuman LM, Mandel JS, Anderson VE, McHugh RB, Hanson MR, Fahlstrom SM, KrivitW, Kersey JH: TheWiskott-Aldrich syndrome in the United States and Canada (1892–1979). J Pediatr 97: 72–78, 1980
Confavreux C, Saddier P, Grimaud J, Moreau T, Adeleine P, Aimard G: Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study. Neurology 46: 1607–1612, 1996
Kinlen LJ: Incidence of cancer in rheumatoid arthritis and other immunosuppressive treatment. Am J Med 78: 44–49, 1985
DeAngelis LM: Primary central nervous system lymphoma as a secondary malignancy. Cancer 67: 1431–1435, 1991
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schabet, M. Epidemiology of Primary CNS Lymphoma. J Neurooncol 43, 199–201 (1999). https://doi.org/10.1023/A:1006290032052
Issue Date:
DOI: https://doi.org/10.1023/A:1006290032052